Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Trial ID or NCT#
NCT00185991
Status
NOT RECRUITING
Purpose
To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
Official Title
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - clinical diagnosis of chorioamnionitis
Exclusion Criteria:
- - maternal renal disease, intrauterine fetal death, allergy to gentamicin
Investigator(s)
Yasser El-Sayed, Professor
Obstetrician and Gynecologist (OB-GYN)
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Contact us to find out if this trial is right for you.
Contact
Yasser El-Sayed
6507233198
View on ClinicalTrials.gov
